Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
The American Journal of Cardiology|October 24, 2007
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trialsGregg W Stone, Simon R Dixon, Cindy L Grines, et al.
The American Journal of Cardiology|July 25, 2006
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)David A Cox, Gregg W Stone, Cindy L Grines, et al.
American Heart Journal|June 20, 2006
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarctionDavid E Kandzari, James E Tcheng, Bernard J Gersh, et al.
Journal of the American College of Cardiology|September 15, 2004
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialMichael G McLaughlin, Gregg W Stone, Eve Aymong, et al.
Circulation|November 26, 2003
Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarctionH Mehrdad Sadeghi, Gregg W Stone, Cindy L Grines, et al.
Journal of the American College of Cardiology|May 3, 2005
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk scoreAmir Halkin, Mandeep Singh, Eugenia Nikolsky, et al.
The American Journal of Cardiology|June 15, 2007
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial)Bruce R Brodie, John Webb, David A Cox, et al.
Journal of the American College of Cardiology|November 22, 2008
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromesDuane S Pinto, Gregg W Stone, Chunxue Shi, et al.
Journal of the American College of Cardiology|July 4, 2006
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trialDuane S Pinto, Gregg W Stone, Stephen G Ellis, et al.
Journal of the American College of Cardiology|July 18, 2006
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV TrialAmeet Bakhai, Gregg W Stone, Elizabeth Mahoney, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|October 24, 2007
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trialsGregg W Stone, Simon R Dixon, Cindy L Grines, et al.
The American Journal of Cardiology|July 25, 2006
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)David A Cox, Gregg W Stone, Cindy L Grines, et al.
American Heart Journal|June 20, 2006
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarctionDavid E Kandzari, James E Tcheng, Bernard J Gersh, et al.
Journal of the American College of Cardiology|September 15, 2004
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialMichael G McLaughlin, Gregg W Stone, Eve Aymong, et al.
Circulation|November 26, 2003
Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarctionH Mehrdad Sadeghi, Gregg W Stone, Cindy L Grines, et al.
Journal of the American College of Cardiology|May 3, 2005
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk scoreAmir Halkin, Mandeep Singh, Eugenia Nikolsky, et al.
The American Journal of Cardiology|June 15, 2007
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial)Bruce R Brodie, John Webb, David A Cox, et al.
Journal of the American College of Cardiology|November 22, 2008
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromesDuane S Pinto, Gregg W Stone, Chunxue Shi, et al.
Journal of the American College of Cardiology|July 4, 2006
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trialDuane S Pinto, Gregg W Stone, Stephen G Ellis, et al.
Journal of the American College of Cardiology|July 18, 2006
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV TrialAmeet Bakhai, Gregg W Stone, Elizabeth Mahoney, et al.
Pageof 17